We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cocktail of Molecules Induces Astrocytes to Transform into Neurons

By LabMedica International staff writers
Posted on 20 Feb 2019
A team of neurobiological researchers developed a simple recipe requiring only three or four small molecules to convert human fetal astrocytes into neurons.

Investigators at Pennsylvania State University (University Park, USA) had previously developed a cocktail of nine small molecules to convert human fetal astrocytes into neurons, but a nine-molecule recipe was difficult to use for clinical applications.

The investigators reported in the February 7, 2019, online edition of the journal Stem Cell Reports that modulation of three to four signaling pathways among the Notch, glycogen synthase kinase 3, transforming growth factor beta, and bone morphogenetic protein pathways was sufficient to induce an astrocyte to transform into a neuron. More...
By using four molecules they could efficiently convert up to 70% of human astrocytes into functional neurons. A cocktail of three of the small molecules also converted astrocytes into neurons, but the conversion rate dropped by about 20%.

The chemically converted human neurons were able to survive for more than seven months in culture, fire repetitive action potentials, and display robust synaptic burst activities. Cortical astrocyte-converted neurons were mostly glutamatergic, while midbrain astrocyte-converted neurons could yield some gamma-aminobutyric acid- producing (GABAergic) neurons in addition to glutamatergic neurons. When administered in vivo through intracranial or intraperitoneal injection, the four-drug combination could significantly increase production of adult hippocampal neurons.

"The biggest problem for brain repair is that neurons do not regenerate after brain damage, because they do not divide," said senior author Dr. Gong Chen, professor of biology at Pennsylvania State University. "In contrast, glial cells, which gather around damaged brain tissue, can proliferate after brain injury. I believe turning glial cells that are the neighbors of dead neurons into new neurons is the best way to restore lost neuronal functions."

"The most significant advantage of the new approach is that a pill containing small molecules could be distributed widely in the world, even reaching rural areas without advanced hospital systems," said Dr. Chen. "My ultimate dream is to develop a simple drug delivery system, like a pill, that can help stroke and Alzheimer's patients around the world to regenerate new neurons and restore their lost learning and memory capabilities. Our years of effort in discovering this simplified drug formula take us one step closer to reaching our dream."

Related Links:
Pennsylvania State University


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Capillary testing on the Atellica analyzers supports the most common laboratory testing needs (Photo courtesy of Siemens Healthineers)

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.